BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9129047)

  • 1. Dose-dependent enhancements by interferon-gamma on functional responses of neutrophils from chronic granulomatous disease patients.
    Ahlin A; Elinder G; Palmblad J
    Blood; 1997 May; 89(9):3396-401. PubMed ID: 9129047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged recombinant interferon-gamma therapy in chronic granulomatous disease: evidence against enhanced neutrophil oxidase activity.
    Woodman RC; Erickson RW; Rae J; Jaffe HS; Curnutte JT
    Blood; 1992 Mar; 79(6):1558-62. PubMed ID: 1312372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease.
    Ezekowitz RA; Orkin SH; Newburger PE
    J Clin Invest; 1987 Oct; 80(4):1009-16. PubMed ID: 2821069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo interferon-gamma induced changes in gene expression dramatically alter neutrophil phenotype.
    Ambruso DR; Briones NJ; Baroffio AF; Murphy JR; Tran AD; Gowan K; Sanford B; Ellison M; Jones KL
    PLoS One; 2022; 17(2):e0263370. PubMed ID: 35113934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotinamide-adenine dinucleotide phosphate oxidase assembly and activation in EBV-transformed B lymphoblastoid cell lines of normal and chronic granulomatous disease patients.
    Dusi S; Nadalini KA; Donini M; Zentilin L; Wientjes FB; Roos D; Giacca M; Rossi F
    J Immunol; 1998 Nov; 161(9):4968-74. PubMed ID: 9794433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroviral-mediated gene transfer of gp91phox into bone marrow cells rescues defect in host defense against Aspergillus fumigatus in murine X-linked chronic granulomatous disease.
    Björgvinsdóttir H; Ding C; Pech N; Gifford MA; Li LL; Dinauer MC
    Blood; 1997 Jan; 89(1):41-8. PubMed ID: 8978275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of p67phox, p47phox or gp91phox in chronic granulomatous disease does not impair leucocyte chemotaxis or motility.
    Zicha D; Dunn GA; Segal AW
    Br J Haematol; 1997 Mar; 96(3):543-50. PubMed ID: 9054662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and molecular effects of recombinant interferon gamma in chronic granulomatous disease.
    Newburger PE; Ezekowitz RA
    Hematol Oncol Clin North Am; 1988 Jun; 2(2):267-76. PubMed ID: 2839459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of lipophilic probes of membrane potential to assess human neutrophil activation. Abnormality in chronic granulomatous disease.
    Seligmann BE; Gallin JI
    J Clin Invest; 1980 Sep; 66(3):493-503. PubMed ID: 6249851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo interferon-gamma therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae.
    Rex JH; Bennett JE; Gallin JI; Malech HL; DeCarlo ES; Melnick DA
    J Infect Dis; 1991 Apr; 163(4):849-52. PubMed ID: 1901332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in-frame triplet deletion within the gp91-phox gene in an adult X-linked chronic granulomatous disease patient with residual NADPH-oxidase activity.
    Jendrossek V; Ritzel A; Neubauer B; Heyden S; Gahr M
    Eur J Haematol; 1997 Feb; 58(2):78-85. PubMed ID: 9111587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma interferon treatment of patients with chronic granulomatous disease is associated with augmented production of nitric oxide by polymorphonuclear neutrophils.
    Ahlin A; Lärfars G; Elinder G; Palmblad J; Gyllenhammar H
    Clin Diagn Lab Immunol; 1999 May; 6(3):420-4. PubMed ID: 10225847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus.
    Morgenstern DE; Gifford MA; Li LL; Doerschuk CM; Dinauer MC
    J Exp Med; 1997 Jan; 185(2):207-18. PubMed ID: 9016870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and prognoses of 23 patients with chronic granulomatous disease followed for 21 years by a single hospital in Japan.
    Kobayashi S; Murayama S; Takanashi S; Takahashi K; Miyatsuka S; Fujita T; Ichinohe S; Koike Y; Kohagizawa T; Mori H; Deguchi Y; Higuchi K; Wakasugi H; Sato T; Wada Y; Nagata M; Okabe N; Tatsuzawa O
    Eur J Pediatr; 2008 Dec; 167(12):1389-94. PubMed ID: 18335239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rac translocates independently of the neutrophil NADPH oxidase components p47phox and p67phox. Evidence for its interaction with flavocytochrome b558.
    Heyworth PG; Bohl BP; Bokoch GM; Curnutte JT
    J Biol Chem; 1994 Dec; 269(49):30749-52. PubMed ID: 7982999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved superoxide-generating ability by interferon gamma due to splicing pattern change of transcripts in neutrophils from patients with a splice site mutation in CYBB gene.
    Ishibashi F; Mizukami T; Kanegasaki S; Motoda L; Kakinuma R; Endo F; Nunoi H
    Blood; 2001 Jul; 98(2):436-41. PubMed ID: 11435314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the IFN-gamma-induced enhancement of superoxide production in CGD-phagocytes caused by increased expression of the p47-phox cytosolic protein.
    Jendrossek V; Damm U; Liese J; Belohradsky BH; Gahr M
    Immunodeficiency; 1993; 4(1-4):187-90. PubMed ID: 8167697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of monocytes by interferon-gamma has no effect on the level or affinity of the nicotinamide adenine dinucleotide-phosphate oxidase and on agonist-dependent superoxide formation.
    Thelen M; Wolf M; Baggiolini M
    J Clin Invest; 1988 Jun; 81(6):1889-95. PubMed ID: 2838524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and carrier detection of chronic granulomatous disease in five families by flow cytometry.
    Crockard AD; Thompson JM; Boyd NA; Haughton DJ; McCluskey DR; Turner CP
    Int Arch Allergy Immunol; 1997 Oct; 114(2):144-52. PubMed ID: 9338608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of superoxide production in monocytes from patients with chronic granulomatous disease by recombinant cytokines.
    Jendrossek V; Peters AM; Buth S; Liese J; Wintergerst U; Belohradsky BH; Gahr M
    Blood; 1993 Apr; 81(8):2131-6. PubMed ID: 8386028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.